Atezolizumab
Human Papillomavirus-Related Squamous Cell Carcinoma of the Penis
M.D. Anderson Cancer Centermonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
11 Active assets in the Human Papillomavirus-Related Squamous Cell Carcinoma of the Penis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Christian Hinrichs | Phase 2 | B |
Fludarabine Christian Hinrichs | Phase 2 | B |
e7 tcr-t cells Christian Hinrichs | Phase 2 | B |
scg142 SCG Cell Therapy Pte. Ltd. | Phase 1/2 | CC |
Tsc-204-C0702 TScan Therapeutics, Inc. | Phase 1 | CC |
View all 11 →
Same molecule, other indications
Atezolizumab is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →